Is CMML up or down today?
CMML is down 0.95% today, last at 288.32. This stock moved -0.95% versus the prior close.
CMML · CMML
CMML (CMML) is trading at 288.32, down 0.95% on the session. CMML sits at the 50% mark of its 52-week range.
Leading the coverage: “Oral Decitabine/Cedazuridine Plus Venetoclax Yields 91% ORR in High-Risk MDS and CMML - OncLive” (Google News Company, 333d ago). CMML is +1.16% since story.
CMML trades on a trailing P/E of 19.3.
Analyst firms are mostly reiterating — no strong directional shift lately.
CMML is down 0.95% today, last at 288.32. This stock moved -0.95% versus the prior close.
Leading the coverage: “Oral Decitabine/Cedazuridine Plus Venetoclax Yields 91% ORR in High-Risk MDS and CMML - OncLive” (Google News Company, 333d ago). CMML is +1.16% since story. Dominant story: CMML volatility spikes as options activity jumps (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
CMML volatility spikes as options activity jumps
CMML in focus ahead of earnings next week
Institutional buyers pile into CMML, filings show
FDA grants orphan drug status to Cardiff’s onvansertib for CMML By Investing.com - Investing.com UK
Oral Azacitidine and Cedazuridine Meets Primary Pharmacokinetic End Point in MDS and CMML - OncLive